ESMO preview: Has Merck's Keytruda lost its mojo? - FiercePharma
For Merck & Co.’s Keytruda, medical conferences have in the past served as platforms to showcase new clinical trophies. But at this year’s European Society for Medical Oncology meeting, the P...
Read more